Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Compare which total market fund to hold in retirement in 2024 and how to balance it with other assets. Focus on cost, tax efficiency, and diversification.
28,509 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
A high-stakes power struggle within the Labour Party erupted this week as Health Secretary Wes Streeting resigned, sp...
A reader invites a friend to act as an informal adviser, only to learn the friend is paid to push certain funds. The ...
America marks 250 years with a focus on risk-sharing as the true engine of progress. The greatest lesson may be the b...
A historic Knicks championship ends a 53-year wait and offers practical leadership and personal finance lessons on pa...
Markets are choppy midway through Q1 2026 as earnings season unfolds. This report ranks the best trading platforms fo...
Signet Jewelers is not just selling rings anymore. A pivot to lab-grown diamonds is reshaping growth and margins. Thi...
Rocket Lab’s stock has faced renewed pressure as the market weighs contracting demand signals and execution risks. Th...
January 2026 saw natural gas price spikes then a rapid collapse, with the UNG ETF tracking every twist. Traders say t...
Eight defendants have been sentenced in a parking-lot phone scam that targeted Navy Federal customers, but two defend...
Investors are eyeing aemetis (amtx) 2025 earnings as the company advances its biofuels and biochemicals projects. Thi...
A leading fiscal watchdog warns that the trump administration’s proposed capital gains policy could lift the national...